Hydrogen Research Study
← Back to Research Library
Preclinical animal evidenceAnimal studyhydrogen-rich water

Hydrogen-Rich Water Ameliorates Autistic-Like Behavioral Abnormalities in Valproic Acid-Treated Adolescent Mice Offspring.

Qingjun Guo, Xi Yin, Meng Qiao, Yujiao Jia, Dandan Chen, Juan Shao, Tyler W Lebaron, Yuan Gao, Haishui Shi, Bin Jia · Frontiers in behavioral neuroscience · 2018

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Molecular Hydrogen Overview
Evidence type Preclinical animal evidence
Publication type Animal study
Hydrogen method hydrogen-rich water

H2HUBB TAKEAWAY

In mice, these data suggest the need for additional research on HRW as a potential preventive strategy for autism and related disorders. These results are preclinical and suggest molecular hydrogen's therapeutic potential in the condition studied. Further human research is needed to establish clinical effectiveness.

What the Researchers Studied

Mice

How Molecular Hydrogen Was Used

Hydrogen-rich water

What the Researchers Found

These data suggest the need for additional research on HRW as a potential preventive strategy for autism and related disorders.

Biological or Mechanistic Findings

Due to its anti-inflammatory and anti-oxidative effects, recent research has demonstrated that molecular hydrogen can serve as a new medical approach for depression, anxiety and traumatic brain injury. The present study aims to investigate the potential effects of hydrogen-rich water (HRW) administration on valproic acid (VPA)-induced autistic-like behavioral deficits, and the associated underlying mechanism in adolescent mice offspring.

Authors’ Conclusion

The authors concluded that these data suggest the need for additional research on HRW as a potential preventive strategy for autism and related disorders. These results are preclinical and suggest molecular hydrogen's therapeutic potential in the condition studied. Further human research is needed to establish clinical effectiveness.